For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding.
Journal Article (Journal Article)
Full Text
Duke Authors
Cited Authors
- Sherwood, M; Piccini, JP
Published Date
- October 2012
Published In
Volume / Issue
- 17 / 5
Start / End Page
- 148 - 149
PubMed ID
- 22345038
Pubmed Central ID
- PMC3936876
Electronic International Standard Serial Number (EISSN)
- 1473-6810
Digital Object Identifier (DOI)
- 10.1136/ebmed-2011-100343
Language
- eng
Conference Location
- England